DataSheet5_CircRNA Microarray Profiling Reveals hsa_circ_0058493 as a Novel Biomarker for Imatinib-Resistant CML.ZIP
Background: CircRNA has appeared as a critical molecular in the development of various cancers. However, the cellular function of circRNAs and exosomal circRNAs has not been well explored in Chronic myeloid leukemia (CML).
Methods: Differentially expressed circRNAs were identified by a human circRNA microarray analysis. The expression of hsa_circ_0058493 in peripheral blood mononuclear cells (PBMCs) and exosomes was verified using quantitative real-time PCR. Short hairpin RNAs against hsa_circ_0058493 were constructed to silence the expression of circ_0058493. CCK8, flow cytometry and EdU assay were performed to investigate the biological functions of circ_0058493.
Results: Hsa_circ_0058493 was significantly overexpressed in the PBMCs of CML patients and high level of circ_0058493 was associated with the poor clinical efficacy of imatinib. Silencing the expression of circ_0058493 significantly inhibited the development of imatinib-resistant CML cells. miR-548b-3p was overexpressed in circ_0058493-downregulated CML cells. Bioinformatic analysis revealed that circ_0058493 might exert its regulatory function acting as a “sponge” of miR-548b-3p. Moreover, hsa_circ_0058493 was significantly enriched in the exosomes derived from imatinib-resistant CML cells.
Conclusion: Hsa_circ_0058493 in PBMCs could be a promising prognostic biomarker and might provide a therapeutic target for CML treatment.
History
References
- https://doi.org//10.1038/s41596-019-0260-5
- https://doi.org//10.1016/s0140-6736(13)62120-0
- https://doi.org//10.3760/cma.j.issn.0253-2727.2016.08.001
- https://doi.org//10.3390/cells8070727
- https://doi.org//10.1186/s12943-018-0936-4
- https://doi.org//10.3324/haematol.2017.174953
- https://doi.org//10.1186/s12943-019-0969-3
- https://doi.org//10.1186/s13046-020-1529-9
- https://doi.org//10.1002/ajh.24249
- https://doi.org//10.1186/s12943-020-1134-8
- https://doi.org//10.1002/jcb.28239
- https://doi.org//10.1038/cr.2015.82
- https://doi.org//10.1126/scitranslmed.3009073
- https://doi.org//10.1016/j.canlet.2015.06.003
- https://doi.org//10.1186/s12943-018-0888-8
- https://doi.org//10.1002/jcp.28732
- https://doi.org//10.1186/s12943-019-1078-z
- https://doi.org//10.1002/1878-0261.12629
- https://doi.org//10.1186/s12943-020-01191-9
- https://doi.org//10.1016/j.omtn.2019.12.025
- https://doi.org//10.1186/s12943-020-01208-3
- https://doi.org//10.1038/s41392-020-00375-5
- https://doi.org//10.1186/s12935-020-01642-9
CC BY 4.0